Fiala

Peptide library › Hormonal & fertility

Octreotide

Also known as Sandostatin, Sandostatin LAR, Mycapssa

FDA-approved drugHormonal & fertility

Long-lasting copy of somatostatin that switches off excess growth hormone and gut hormones; used for acromegaly and hormone-producing tumours.

What people use it for

What Octreotide does in the body

Mimics somatostatin, the body's 'off switch' for many hormones, including growth hormone, insulin, glucagon and gut hormones. It lasts far longer than natural somatostatin.

Strength of evidence

Strong: established for decades.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 1988, with a monthly depot later and an oral capsule (Mycapssa) in 2020. Prescription only.

How it's taken

Route: Injection under the skin, monthly depot into a muscle, or capsules

How long it lasts (half-life): About 1.5 to 2 hours; the depot lasts about 4 weeks

Storage

Ampoules refrigerated; the depot kit is refrigerated before use.

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Octreotide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Octreotide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Hormonal & fertility